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Giant ankyrin-B (ankB) is a neurospecific alternatively spliced
variant of ANK2, a high-confidence autism spectrum disorder
(ASD) gene. We report that a mouse model for human ASD muta-
tion of giant ankB exhibits increased axonal branching in cultured
neurons with ectopic CNS axon connectivity, as well as with a
transient increase in excitatory synapses during postnatal develop-
ment. We elucidate a mechanism normally limiting axon branching,
whereby giant ankB localizes to periodic axonal plasma membrane
domains through L1 cell-adhesion molecule protein, where it cou-
ples microtubules to the plasma membrane and prevents microtu-
bule entry into nascent axon branches. Giant ankB mutation or
deficiency results in a dominantly inherited impairment in selected
communicative and social behaviors combined with superior execu-
tive function. Thus, gain of axon branching due to giant ankB-
deficiency/mutation is a candidate cellular mechanism to explain ab-
errant structural connectivity and penetrant behavioral consequences
in mice as well as humans bearing ASD-related ANK2 mutations.
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Autism spectrum disorders (ASD) are heritable neuro-developmental conditions affecting around 1% of the pop-
ulation with shared features of impaired reciprocal social
behavior and restricted or repetitive behavior. Genetic risk for
ASD is conferred by variants of up to 1,000 different genes, with
functions that are believed, based on unbiased pathway analyses,
to converge on synaptic activity and gene regulation (1, 2). A
much smaller set of about 25 high-confidence ASD genes have
been compiled by the Simons Foundation (https://gene.sfari.org/
about-gene-scoring/) utilizing multiple criteria, including inde-
pendent replication. These highly penetrant genes promise to
provide new insights into the cellular origins of ASD through
direct experimentation.
Among the high-confidence ASD genes, ANK2 is of particular
interest in that it has not been directly linked to either gene
regulation or synaptic function, and mutations resulting in an
ASD diagnosis are mostly nonsyndromic and are compatible with
normal intellectual ability (Dataset S1) (2, 3). Autism associated
with ANK2 mutation is thus distinct from syndromic autism, which
coexists with intellectual disability and neurological comorbidities,
such as seizures, as well as systemic abnormalities. ANK2 is a
member of the ankyrin gene family that, together with their
spectrin partners, is responsible for micrometer-scale organiza-
tion of vertebrate plasma membranes in a variety of physiological
contexts (4, 5). ANK2 encodes 2 major ankyrin-B (ankB) poly-
peptides, one of 220 kDa that is expressed in multiple tissues and
the other of 440 kDa (referred to as giant ankB) that is expressed
only in the nervous system (5–7). The 220-kDa ankB functions in
polarized transport of intracellular organelles as a PI3P-binding
adaptor for dynactin, and also promotes internalization of Glut4
(8–11). Mice lacking both ankB polypeptides die neonatally with
loss of long axon tracts, including pyramidal tracts and the corpus
callosum (9, 12). Mutations targeting both 220-kDa ankB and
giant ankB are associated with cardiac arrhythmia (13, 14), as
well as age-dependent obesity (10, 12, 15).
Giant ankB includes 2,133 additional residues encoded by a
6.4-kb exon (exon 37) that are inserted between the spectrin-
binding and death domains due to alternative splicing. (Fig. 1A)
(16, 17). Giant ankB is likely extended in shape since it shares
sequence similarity with giant ankG, which has been directly im-
aged at axon initial segments by platinum replica immunoelectron
microscopy as an elongated molecule 150 nm in length (18).
Three human ANK2 ASD mutations (P1843S, R2608 frameshift,
and E3429V) are located in exon 37, and these mutations only
affect giant ankB, while others (R895*, R990*, Q3683fs) affect
both giant ankB and 220-kDa ankB. R895* and R990* mutations
likely result in haploinsufficiency of 220-kDa ankB and giant
ankB based on reduced expression of both ankB polypeptides in
a mouse model bearing nonsense mutation in exon 22 of ANK2
(Fig. 1 C and F) (12, 13). This distribution of ANK2 mutations
and clinical history of probands bearing these mutations suggests
that deficiency/mutation of giant ankB alone is sufficient to cause
nonsyndromic ASD.
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Here we elucidate a penetrant behavioral phenotype in the
first mouse models for human ANK2 mutations related to ASD,
and present evidence that giant ankB is required for normal
structural connectivity in the central nervous system. We find a
cellular function for giant ankB in repressing ectopic axon
branching that may explain aberrant connectivity. We further
establish that giant ankB, and not 220-kDa ankB, is the partner
for L1 cell-adhesion molecule protein (shortened as L1CAM),
and that giant ankB and L1CAM collaborate to coordinate
cortical microtubules and prevent stabilization of axonal filopodia
that can mature into branches. Together, these findings validate
ANK2 as a functional target for ASD mutation and establish
axon branching as a potential cellular substrate for ASD.
Results
Giant ankB Mutant Mice Exhibit Penetrant Behavioral Deficits. To
understand the behavioral and cellular consequences of giant
ankB ASD mutation in a mammalian animal model, we used
CRISPR to introduce a P2580fs mutation in C57BL/6J mice that
was similar to the R2608fs human ANK2 frameshift mutation in
exon 37 of ANK2 (Fig. 1 A and C and Dataset S1). R2608fs was a
de novo mutation found in an individual diagnosed with “per-
vasive developmental disorder–not otherwise specified,” which is
an older term for individuals with mild forms of autism. This
individual had a normal IQ, and lacked attention deficit, sei-
zures, or other neurological symptoms (Dataset S1) (3). The
DNA sequence corresponding to R2608 has similarity with other
sites in the mouse genome. To minimize the likelihood of off-
target excisions from a guide RNA (gRNA) targeting the precise
human mutation site, we targeted P2580, 28 residues away from
the actual human site, since the gRNA for this site had higher
genomic selectivity. A frameshift mutation at P2580 was con-
firmed by DNA sequencing.
ABe37fs/fs and ABe37fs/+ mice are born at normal Mende-
lian ratios, and are fertile, with normal body weights and life-
spans (SI Appendix, Fig. S1). ABe37fs/fs mice lack 440-kDa
ankB, but instead express a truncated 290-kDa polypeptide and
normal levels of 220-kDa ankB (Fig. 1E). Expression of human
cDNA bearing the R2608fs mutation in human embryonic kid-
ney cells also produced a 290-kDa polypeptide (Fig. 1D). The
290-kDa ankB lacks both the death domain, which interacts with
RabGAPL1 (11), as well as the C-terminal regulatory domain in
addition to about 90 kDa of exon 37-encoded sequence. The
290-kDa ankB also is expressed at about half the level of 440-kDa
ankB (Fig. 1 E and F). The ABe37fs mutation thus results in
reduced expression of a truncated giant ankB polypeptide lacking
highly conserved domains.
We examined effects of the ABe37fs mutation on behavior.
We initially screened homozygous ABe37fs/fs males for ASD-
like core features (deprivation-induced ultrasonic vocalization,
social behavior, repetitive responses) as well as potential
comorbidities (anxiety, motor, and cognitive performance). We
first examined social affiliation in adult mice (19). There were no
significant genotype differences in their responses to the non-
social and social stimuli (Fig. 2A). Both genotypes preferred the
social over the nonsocial stimulus. Importantly, no genotype
differences were observed in the duration of contacts with the
stimuli (SI Appendix, Table S1), demonstrating that the mice
interacted with the stimuli to similar extents. In a test for re-
petitive behavior, mice were misted with water and groom bouts
were analyzed. ABe37fs/fs mice showed a 2-fold increase in
grooming bouts relative to the ABe37+/+ controls (P = 0.006)
(Fig. 2B), indicative of more persistent repetitive behavior.
Nevertheless, motor performance on the steady-speed and ac-
celerating rotarod was normal (Fig. 2C and SI Appendix, Fig.
S2A); however, spontaneous locomotor activity in the open field
was decreased in the mutants (P = 0.04) (SI Appendix, Fig. S2 B,
Left). Rearing behavior between genotypes was not significant
(SI Appendix, Fig. S2 B, Right). Finally, ABe37fs/fs mice did not
exhibit anxiety-like behaviors in the light–dark emergence test
(SI Appendix, Table S2).
Examination of basic cognitive functions revealed normal short-
and long-term novel object recognition memory (Fig. 2D) with no
genotype differences in the duration of object contacts (SI Ap-
pendix, Table S1), indicating that both groups interacted with the
objects for a similar amount of time. Additionally, learning and
memory were not altered in the acquisition and reversal phases of
the Morris water maze (SI Appendix, Fig. S3 A and B).
We next evaluated vocal communication in the ABe37fs
mice. First, we examined innate communication in a maternal
deprivation-induced ultrasonic vocalization (USV) assay. ABe37fs/fs
PND7 pups emitted fewer USVs compared with controls (Fig. 2 E,
Left). Similar phenotypes of altered pup USVs are reported in
ASD-associated Shank3-null mice (20). We also analyzed sexual
responses as a form of social behavior. In a pheromone-induced
urine territory-marking assay, where a sexually primed male marks



























































































   
   
   

















Fig. 1. Mouse models for ANK2 ASD mutations. (A) Schematic of giant ankB
and 220-kDa ankB polypeptides with de novo ANK2 ASD variants mapped.
Binding sites of the pan ankB antibody (blue) or the giant ankB specific
antibody (red) are marked with asterisks. (B) In-gel Western of a neuronal
culture versus a glia cell culture with pan ankB antibody (panAB). (C) Sche-
matic of gene modification and affected polypeptides in 3 mouse models of
ANK2 deficiency/mutation. (D) In-gel Western of HEK293T cell lysates that
were transfected with giant ankB cDNA or giant ankB-R2608fs human
frameshift cDNA using the giant ankB-specific antibody (gAB). Asterisks
mark a 290 kDa polypeptide. (E) In-gel Western of brain lysates from WT or
ABe37fs/fs (ABfs/fs) mice using giant ankB specific antibody (gAB). Asterisks
mark a 290 kDa polypeptide. (F) Quantification of ankB polypeptides in
mouse models of ANK2 deficiency/mutation normalized to WT mouse (n = 3
mice per genotype for all immunoblots).








spot, ABe37fs/fs males made small or no territory markings in
response to the female urine (Fig. 2 F, Lower Left). Impor-
tantly, no obvious deficits in olfaction were detected (SI Ap-
pendix, Fig. S2 D, Upper Left and Lower Left). This lack of
territory marking is indicative of a subordinate sense of rank in
the male mouse. Interestingly, decreased pup USVs and re-
duced territory marking are reported in Shank1-null mice (21).
It should be emphasized that heterozygous ABe37fs/+ mice
exhibited the same behavioral differences as the homozygous
mutants (Fig. 2 E and F, Left). Hence, these deficiencies are








Fig. 2. Giant ankB mutant mice exhibit abnormal communication, sexual behavior responses, repetitive behavior, and increased executive function in the absence
of ASD-associated comorbidities. (A) ABfs mice show a normal preference for the social stimulus in the social affiliation test. RMANOVA, n = 14 to 16. (B) Grooming
bouts are increased in mutants with water misting. Unpaired t test, n = 16. (C) Motor performance on the constant speed rotarod is normal. RMANOVA, n = 8. (D)
Normal short- and long-termmemory in the novel object recognition memory task. RMANOVA, n = 15 to 16. (E) USVs from PND 7 mice are decreased across 3 giant
ankB-deficient strains. One-way ANOVA, n = 23 to 29 (ABe37fs); unpaired t test, n = 8 to 13 (ABe37floxed), n = 6 to 7 (ABe22). (F) Decreased territory marking in
response to estrous female urine in the 3 giant ankB-deficient strains as determined by the number of male urine marking made upon exposure to female urine. (F,
Upper) One-way ANOVA, n = 22, 7, 18 (ABe37fs); unpaired t test, n = 4 to 7 (ABe37floxed), n = 5 to 6 (ABe22). (Lower) Representative traces from ninhydrin-exposed
urine marks from ABe37fs males, female estrous urine is shown as a red circle. (G) Acquisition performance in the water T-maze is normal. RMANOVA, n = 10 to 20
(ABe37fs), n = 9 to 14 (ABe37floxed), n = 5, 21 (ABe22). (H) Superior performance in 2 strains with giant ankB mutations on the first reversal trial in the water T-
maze. (Upper) Number of errors on trial one reversal. One-way ANOVA, n = 6 to 10 (ABe37fs); unpaired t test, n = 7 (ABe37floxed), n = 5 to 11 (ABe22). (Lower)
Reaching the hidden platform within 1 min (yes = 1, no = 0). χ2 test: ABe37fs: n = 10 to 18 (ABe37fs), n = 9 to 14 (ABe37floxed), n = 5, 21 (ABe22). (Right)
Representative traces of ABe37fs performance on reversal trial 1. T-maze in gray; black line shows the trajectory of a mouse from the start box (green cross) to the
arm with the hidden platform (red rectangle). All numeric data are presented as means ± SEM; ns, not significant; *P < 0.05, **P < 0.01, ***P < 0.001, versus the
WT or Cre control; ns, not significant. n value represents mice per genotype. See SI Appendix for full statistical description of figure.
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Finally, we tested executive function in the water T-maze.
Although acquisition of the T-maze was accelerated in the
ABe37fs/fs mice, this effect did not reach statistical significance
(Fig. 2 G, Upper). Interestingly, when executive function was
evaluated during the reversal phase of the water T-maze (22),
ABe37fs/fs made fewer errors and had greater success in
reaching the hidden platform than the WT controls (Fig. 2 H,
Left and far Right). This increased ability was evident also in the
ABe37fs heterozygotes, suggesting a penetrant gain-of-function
in these mutants. The enhanced performance on the first trial of
reversal could be due to the rapid recognition by mutants that
the hidden platform had been moved to a new location. Sub-
sequent testing over time showed that all groups acquired this
reversal task (SI Appendix, Fig. S3 C, Top).
To determine whether the phenotype in ABe37fs/fs mice
was due to loss of giant ankB function, we examined 2 other
mouse strains with giant ankB mutations: ABe37f/f; Nestin-Cre
(ABe37floxed) mice, where giant ankB is lost in ∼90% of neural
progenitors, and heterozygous ABe22*/+ mice (models for hu-
man R895* [c.2683C > T], R990* [c.2968C > T] de novo non-
sense mutations associated with ASD) (3), which have a stop
codon inserted into exon 22 producing nonsense-mediated decay
and a 50% reduction in both the 220-kDa and giant ankB
polypeptides (Fig. 1 A and D). Behavioral testing replicated the
results with the ABe37fs/fs mice, demonstrating that both the
ABe37fs/+ and ABe22*/+ heterozygotes also displayed deficits
in both the USV and territory-marking tests (Fig. 2 E and F,
Center and Right, and SI Appendix, Fig. S2C). The same slight
increase in acquisition performance in the water T-maze was
observed in both the ABe37floxed mutants and ABe22*/+ mice
(Fig. 2H). Of note, the enhanced cognitive flexibility in the re-
versal phase of the water T-maze was only reproduced in the
2 strains with targeted deficiency/truncation of giant ankB (i.e.,
ABe37fs and ABe37floxed mice) (Fig. 2 H, Left, Center, and far
Right, and SI Appendix, Fig. S3 D, Upper). This superior response
was not observed in ABe22*/+ mice that had reductions in both
giant ankB and 220 kDa ankB (Fig. 2 H, Right, and SI Appendix,
Fig. S3 D, Lower). Again, the overall ability to make the correct
first turn across the 4 test days in reversal were similar to those of
the ABe37fs mutants and were indistinguishable in these other
2 lines of mutants and their controls (SI Appendix, Fig. S3C).
Collectively, these results indicate that giant ankB-deficiency results
in a dominantly inherited impairment in selected communicative
and social behaviors combined with superior executive function.
Giant ankB Mutation Transiently Affects Excitatory Synapses. We
next sought to identify molecular and cellular consequences of
giant ankB mutation/deficiency that could provide a rationale for
the altered behavior. Expression of giant ankB has previously
been reported to be restricted to the nervous system, which in-
cludes both neurons and glial cells (5–7). To determine the
identity of cells expressing giant ankB, we performed immuno-
blots of cultures of either neurons alone or astrocytes alone.
Strikingly, giant ankB was expressed only in neurons, while 220-kDa
ankB was expressed in both neurons and astrocytes (Fig. 1B). We
therefore focused on possible effects of giant ankB mutation on
neuronal function.
Many ASD-related genes function in synaptic signaling (2).
We therefore investigated the effects of ABe37fs mutation on
synapse number and function at postnatal day (PND) 28 (cor-
responding to adolescence in mice) and adulthood (PND 60).
The number of presynaptic puncta identified by synaptophysin
immunofluorescence labeling was increased in the somatosen-
sory cortices of heterozygous and homozygous ABe37fs mice at
PND 28 but returned to normal by PND 60 (SI Appendix, Fig.
S4A). We further visualized dendritic spines of pyramidal neu-
rons utilizing Golgi-Cox labeling and found an increase in the
number of mature spines at PND 28 that also was normalized by
PND 60 (SI Appendix, Fig. S4B).
We next evaluated the function of synapses in the ABe37fs
mice at PND 28 and PND 60 using electrophysiology. Whole-cell
patch-clamp recordings from the somatosensory region of acute
brain slices at PND 28 revealed an increase in frequency and
amplitude of miniature excitatory postsynaptic currents
(mEPSCs) in ABe37fs/fs neurons, with no change in miniature
inhibitory postsynaptic currents (mIPSCs) (Fig. 3A), suggesting
that loss of giant ankB selectively increases the number of ex-
citatory synapses at PND 28. This selective effect on excitatory
synapses was also seen by immunofluorescence labeling of
vGlut2 (excitatory presynaptic marker) and vGAT (inhibitory
presynaptic marker), where vGlut2 was significantly increased at
PND 28 in both the homozygote and heterozygote ABe37fs mice
and vGAT was not changed among groups (SI Appendix, Fig.
S4B). Interestingly, increased numbers of mEPSCs was accom-
panied by a decreased excitability of neurons. At PND 28, we
found a decreased paired-pulse ratio, and thus less facilitation of
a second EPSC (Fig. 3 C, Left) and a decreased action potential
firing rate at fixed levels of current injection (Fig. 3 D, Left). The
reduced excitability is likely a postsynaptic mechanism of ho-
meostasis that compensates at least partially for increased ex-
citatory input (23). This synaptic scaling might explain why the
increased number of excitatory synapses did not induce obvious




Fig. 3. Synaptic function in PND 28 and PND 60 ABe37fs mice. (A and B)
Quantification of mEPSCs and mIPSCs at PND 28 and PND 60 in acute slices
from mice using whole-cell patch-clamp recording. Dots represent individual
neurons. (n = 10 mice per genotype). (C) Quantification of paired-pulse fa-
cilitation generated by an interpulse interval (50 to 150 ms) in PND 28 and
PND 60 mice (n = 8 mice per genotype). (D) Quantification of action po-
tentials generated by direct intracellular current injections in current-clamp
recordings in PND 28 and PND 60 mice. n = 8 mice per genotype; Mean ±
SEM; (A and B) t test; (C and D) repeated measures 2-way ANOVA, Bonferroni
post hoc test; *P < 0.05, **P < 0.01; ns, not significant.








Similar to synapse numbers, the changes in synaptic physiology
at PND 28 were also transient. By PND 60 mEPSC amplitude,
excitability, and the paired-pulse ratio were all indistinguishable
from controls, while mEPSC frequency was decreased (Fig. 3 B–
D, Right). The restoration of normal synaptic physiological prop-
erties at PND 60 may result from synaptic pruning and will be
important to study in more detail. The transient change of synapse
numbers at PND 28 might contribute to some behavior changes
found in the young mice. However, giant ankB mutation has no
significant effect on synapse number or function in adult mice.
ABe37fs/fs Mutation Impairs Giant ankB Binding to L1CAM in Axons.
Given the small effects of the giant ankB mutation on synaptic
function in adult mice, we searched for additional cellular tar-
gets, using as a guide the previously established localization of
giant ankB in axons and association of ankB polypeptides with
the axonal cell-adhesion molecule L1CAM (5, 6, 24). Deficiency
of both 220-kDa and giant ankB in ABe22* mice results in loss of
L1CAM from premyelinated axons during postnatal develop-
ment, while NCAM was unaffected (12). To directly address
which ankB isoform was a L1CAM partner in vivo, we performed
a proximity ligation assay (PLA) in sections of brain tissue using
antibodies specific for L1CAM and either both ankB polypep-
tides or only giant ankB (Fig. 4 A and B). PLA uses antibodies to
detect 2 proteins and gives a signal when proteins are closer than
∼40 nm (25). We observed a strong proximity signal (6.6 ±
0.2 arbitrary units) along axon tracts of the corpus callosum in
WT mice using 1 antibody specific for the cytoplasmic region of
L1CAM and another antibody recognizing both the 220-kDa
ankB and giant ankB (Fig. 4 C, Left and Top, and Fig. 4D).
This proximity signal was markedly diminished in ABe37f/f;
Nestin-Cre mice (2.1 ± 0.2 arbitrary units; P = 0.0001), which
lack giant ankB but still express 220-kDa ankB (Fig. 4 C, Left and
Middle, and Fig. 4D). The proximity signal was also reduced in
L1CAM Y1229H mice (P = 0.0001; 1.4 ± 0.1 arbitrary units),
where L1CAM lacks ankyrin-binding activity (26) (Fig. 4 C, Left
and Bottom, and Fig. 4D). These experiments establish that giant
ankB, and not 220-kDa ankB, interacts with L1CAM in vivo in
axon tracts of the corpus callosum, and confirm that the Y1229H
mutation of L1CAM prevents its interaction with ankB (26). The
structural basis for selective binding of L1CAM to giant ankB is
unknown, since L1CAM associates with the ANK repeat domain
shared by both ankB polypeptides. One hypothesis is that 220-kDa
ankB is autoinhibited by interaction of its regulatory domain with
ANK repeats (27), and this inhibition is lost by giant ankB due
to insertion of the exon 37-encoded extended sequence separating
N-terminal ANK repeats from the C-terminal regulatory domain.
We next determined if the truncated 290-kDa ankB poly-
peptide expressed in ABe37fs/fs mice interacts with L1CAM by
performing PLAs using an antibody (gAB) raised against the
exon 37-encoded sequence that recognizes the 290-kDa trun-
cated ankB polypeptide (Fig. 4 A and B). Remarkably, axons
from ABe37fs/fs mice exhibited a reduction in the proximity li-
gation signal (P = 0.0003; WT = 6.5 ± 0.5; ABfs/fs = 3.5 ± 0.5)
even though 220-kDa ankB was still expressed and 290-kDa
ankB retains the L1CAM binding-site (Fig. 4 C, Right, and Fig.
4D). One explanation for loss of the ankB/L1CAM interaction in
ABe37fs/fs mice is that the 290-kDa ankB truncated polypeptide
is expressed at reduced levels (Fig. 1 E and F). However, it also is
possible that the function of 290-kDa ankB is impaired due to
loss of its death domain and regulatory domain. To better un-
derstand why 290-kDa giant ankB lost interaction with L1CAM
in the corpus callosum, we examined the distribution of giant
ankB and 290-kDa ankB in cultured hippocampal neurons. In
WT neurons, giant ankB is enriched in axons compared with
dendrites (axon/dendrite ratio = 2.9 ± 0.2) (SI Appendix, Fig. S5 A
and B), which is consistent with high levels of giant ankB in the
corpus collosum of brain sections. In ABe37fs/fs neurons, 290-kDa
ankB lost its axonal polarity and was equally expressed in axons
and dendrites (axon/dendrite ratio = 1.2 ± 0.2; P < 0.0001) (SI
Appendix, Fig. S5 A and B). Interestingly, L1CAM also exhibited a
reduced axon/dendrite polarity in ABe37fs/fs neurons (SI Appen-
dix, Fig. S5 A and B). We also evaluated ankB/L1CAM interaction
in neurons using the proximity assay. WT neurons showed a strong
proximity signal that was highly enriched to axons (SI Appendix,
Fig. S5 C, Upper). In contrast, ABe37fs/fs neurons exhibited a
marked decrease in proximity signal in axons accompanied by an
increase of signal in dendrites (SI Appendix, Fig. S5 C, Lower). The
proximity signal in ABe37fs/fs neurons exhibited a near complete
loss of axonal polarity where the axon to dendrite ratio dropped
from 2.2 ± 0.1 in WT neurons to 1.0 ± 0.1 in mutant neurons (P <
0.0001) (SI Appendix, Fig. S5B). These results suggest that func-
tional interaction between L1CAM and giant ankB in axons is
further reduced because of loss of axonal targeting of the 290-kDa
truncated polypeptide. Finally, we evaluated effects of ABe37fs/fs
mutation on L1CAM protein expression level and patterning in
brain tissue (SI Appendix, Fig. S5 C and D). Overall, L1CAM
protein levels were unchanged, although the level of L1CAM
labeling in the corpus callosum was reduced relative to labeling









































































Fig. 4. ABe37fs/fs mutation impairs ankB–L1CAM interaction in axons. (A)
AnkB antibody binding sites are marked with asterisks in the schematic of
220-kDa ankB and giant ankB (blue, pan ankB antibody; red, giant ankB
specific antibody). (B) Immunostaining for giant ankB (gAB), L1CAM, and
pan ankB (panAB) in corpus callosum of PND 28 mouse brain coronal sections
(Scale bars, 50 μm). (C) PLA signal in the corpus callosal (cc) region of in-
dicated mouse strains using L1CAM antibody combined with either pan ankB
antibody (Left) or giant ankB antibody (Right). Nuclei are in blue (Scale bars,
50 μm). (D) Quantification of PLA signal. Mean ± SEM; ***P = 0.003; ****P =
0.0001, 1-way ANOVA followed by Dunnett’s multiple-comparisons test; n = 3.
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experiments establish that giant ankB is the partner for L1CAM
in axons, and that ABe37fs/fs mice experience a major loss in
giant ankB–L1CAM interaction in their long axon tracts.
Giant ankB–L1CAM Interaction Limits Axon Branching. Y1229H
mutation in the ankyrin-binding motif of L1CAM eliminates its
ankyrin-binding activity (Fig. 4 C, Bottom), and results in axon-
targeting defects and ectopic axon projections in the retinocollicular
pathway of mice as well as a neurodevelopmental syndrome in
humans (26, 28). Since L1CAM interaction with giant ankB in
axons also is impaired due to ABe37fs mutation (Fig. 4 C, Right
and Fig. 4D), we hypothesized that ABe37fs/fs neurons would
exhibit altered axon projections.
To evaluate potential effects of mutation of giant ankB and
L1CAM on axonal morphology, we examined cultured hippo-
campal neurons at 4 d of culture after axodendritic polarity had
been established (29). We found no obvious difference in the
polarity of neurons based on restriction of the dendritic marker
MAP2 to dendrites in WT, ABe37fs/fs, and L1CAM Y1229H
neurons (Fig. 5A and SI Appendix, Fig. S6A). However, using
transfected soluble GFP as a cytoplasmic fill, we imaged neu-
ronal processes and found that mutant neurons show increased
axon branching (P = 0.0004; WT = 1.2 ± 0.6 branches/100 μm;
ABfs/fs = 2.3 ± 1.0 branches/100 μm) (Fig. 5 A and B) without a
change in primary axon length or dendritic morphology (SI Ap-
pendix, Fig. S6B). The gain of axon branches was penetrant in
heterozygotes, since we observed increased axon branching in
ABe37fs/+ neurons (P = 0.007; WT = 1.7 ± 0.2; ABfs/+=2.8 ±
0.3) (Fig. 5 B, Right). We also observed increased branching in
neurons from L1CAM-Y1229H mice (P = 0.004) without a
change in primary axon length or dendritic morphology (WT =
1.1 ± 0.2 branches/100 μm; L1CAM-Y1229H = 3.1 ± 0.7/
100 μm) (Fig. 5 C, Right, and SI Appendix, Fig. S6C).
To determine if the branching phenotype in ABe37fs/fs neurons
is caused by loss of giant ankB, we performed rescue experiments
by transfection with giant ankB. The increase in axon branching in
cultured ABfs/fs neurons was restored to normal levels by trans-
fection with giant ankB cDNA (1.5 ± 0.7 branches/100 μm) (Fig. 5
B, Left). We also examined neurons of ABe37f/f; Nestin-Cre mice
where giant ankB is missing and 220-kDa ankB is up-regulated by
40% (Fig. 1 C and F). ABe37f/f; Nestin-Cre neurons also exhibit a
similar increase in axon branching to ABfs/fs neurons (P = 0.007;
ABe37f/f =1.0 ± 0.1 branches/100 μm; ABe37f/f; Nestin-
Cre =1.9 ± 0.2 branches/100 μm) (Fig. 5 C, Left). Thus, in-
creased axonal branching is a gain of cellular activity that results
from loss of giant ankB or its interaction with L1CAM and not
from a dominant-negative effect from the truncated 290-kDa ankB.
Giant ankB Recruits Axonal Microtubules to the Plasma Membrane.
Axon branches begin as actin-based filopodia that can form ei-
ther at growth cones or laterally from the axonal shaft and
subsequently are invaded by microtubules (30, 31). To determine
the origin of axon branches in ABe37fs/fs and L1CAM Y1229H
axons, we employed time-lapse imaging using the microtubule-
end binding protein 3 (EB3)-tandem tomato as a fluorescent
marker for fast-growing ends of microtubules as well as the
axoplasm. We did not observe a difference in growth cone
branching events but did record increased frequency of EB3-
labeled microtubule ends leaving the axon axis (Fig. 6 A and B
and Movie S1) and entering filopodia (Fig. 6C and Movie S2) in
both ABe37fs/fs (P = 0.002 for nonaxial EB3; P = 0.001 for in-
vading EB3) and L1CAM Y1229H neurons (P = 0.03 for nonaxial
EB3; P = 0.004 for invading EB3). Moreover, EB3-tdTM dy-
namics revealed a small but statistically significant decrease in
run length (SI Appendix, Fig. S7), indicating increased dynamic
behavior of microtubules in ABe37fs/fs and L1CAM Y1229H
neurons. These observations indicate that loss of either giant
ankB or giant ankB–L1CAM interaction result in increased axon
branching distributed along the axon shaft, which is due to the
formation of new branches containing fast-growing microtubule
ends (Fig. 6E). Collateral axon branching requires microtubules
to stabilize nascent actin-based filopodia (30, 31), suggesting the
possibility that the increased branching in ABe37fs/fs neurons
may result from altered microtubule organization. In support of
a critical role for microtubules in giant ankB-related branching,
acute treatment of ABe37fs/fs neurons with low concentrations
of taxol (0.5 nM from day in vitro 3 to 3.5), which stabilizes
microtubules, resulted in a marked reduction in axon branches
(DMSO-treated: 3.4 ± 1.7 branches/100 μm; taxol treated: 1.3 ±
0.7 branches/100 μm) (Fig. 6D).
To examine the effect of ABe37fs and L1CAMY1229H muta-
tions on the subcellular distribution of microtubules in vivo, we
imaged cross-sections of unmyelinated axons in the corpus cal-
losum from brains of PND 28 mice using transmission electron
microscopy (Fig. 7A). Control axons exhibited a cortical micro-
tubule population centered around 20 to 30 nm from the plasma
membrane. In contrast, microtubules in ABe37fs/fs and L1CAM
Y1229H axons were arranged in a broader, lower amplitude peak
shifted to 40 to 50 nm from the membrane (Fig. 7B). Notably, the
number of axonal microtubules was unchanged, indicating that the
cortical population was displaced rather than disassembled (SI
Appendix, Fig. S8). Taken together, these results show that giant
ankB mutation and loss of giant ankB–L1CAM interaction causes
loss of the cortical microtubule population in axons in vivo.
To further explore how cortical microtubules were specifically
affected in ABe37fs/fs and L1CAM Y1229H neurons, we used
stimulated emission depletion (STED) imaging to resolve the
subcellular localization of giant ankB and L1CAM on the plasma







































































Fig. 5. Increased axonal branching in giant ankB mutant and L1CAM-
Y1229H neurons. (A) Fluorescence images from GFP-transfected 4-d-old
cultured WT and Abe37fsfs hippocampal neurons stained with MAP2 anti-
body. Images are inverted for a better contrast (axon branches are marked
by red asterisks; blue arrowheads point to the cell body of the transfected
neurons) (Scale bars, 50 μm). (B and C) Quantification of axon branching
from the indicated conditions. Mean ± SEM; **P < 0.01, ***P < 0.001; ns, not
significant; 1-way ANOVA followed by Dunnett’s multiple-comparisons test;
from left to right: n = 19, 22, and 11 for panel 1; n = 18, 19 for panel 2; n =
10, 10 for panel 3; n = 18, 15 for panel 4.








axonal giant ankB and L1CAM molecules were regularly spaced
along the length of axons with a 190-nm periodicity, indicating
that they were likely patterned by spectrin-actin rings (Fig. 7 C
and D) (32). The periodicity of giant ankB and L1CAM was lost
in both ABe37fs/fs and L1CAM Y1229H cultured neurons, where
both proteins exhibited a wider, irregular, and unsynchronized
distribution of spacing (Fig. 7 C, Middle and Bottom, Fig. 7 D,
Lower, and Fig. 7 E, Right). In contrast, F-actin rings persisted with
unaltered periodicity (Fig. 7 C Top, Fig. 7 D, Upper Left, and Fig. 7
E, Left). These data indicate that a direct L1CAM–giant ankB
interaction is required for colocalization of L1CAM and giant
ankB in periodic axonal microdomains (Fig. 7F). Periodic L1CAM
nanodomains were recently reported to be aligned between axons
(33). Giant ankB mutation and loss of L1CAM–giant ankB in-
teraction may impair this this level of axon–axon organization.
Increased CNS Axon Connectivity in ABe37fs/fs Mice. Branches
formed at axonal shafts normally increase axon coverage and
may contribute to increased network connectivity (34). We
sought to determine if increased axon branching occurred in
vivo. We sparsely labeled neurons in mouse cortex by adeno-
associated virus infection of a soluble eGFP driven by a neuron-
specific promotor. Two weeks after injection, cortical pyramidal
neurons were imaged by confocal microscopy in serial z-sections to
track the basal axons. Axons and dendrites were traced and the
axon branches were quantified. Due to the low signal-to-noise
(low axonal GFP signal and signal from the tissue), we could
only track the axon for ∼300 μm from the cell body. Along this
distance, axon branches were rarely observed in all genotypes
(ABe37+/+, ABe37fs/+ or ABe37fs/fs) (SI Appendix, Fig. S9). It is
likely that axon-branching in vivo has additional mechanisms of
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Fig. 6. Giant ankB represses axon branching through preventing microtu-
bule growth into filopodia. (A) Axons from single-frame and 2-min time-
lapse stacked images of EB3-tdTM–transfected neurons (Scale bar, 5 μm).
Red asterisks indicate EB3 comets and blue arrowheads indicate nonaxis
EB3 comets. (B) Quantification of the number of nonaxis EB3 comets
(mean ± SEM; **P < 0.01; 1-way ANOVA followed by Dunnett’s multiple-
comparisons test; n > 10 cells). (C, Left) Time-point images from time-lapse
movie represent the progress of invasion of microtubules into newly formed
filapodia in an ABe37fs/fs (ABfs/fs) neuron axon shaft (Scale bar, 5 μm).
(Right) Quantification of the number of the filopodia with EB3 comets in-
vaded (mean ± SEM; **P < 0.01; 1-way ANOVA followed by Dunnett’s
multiple-comparisons test; n > 10 cells). (D) Fluorescent images of 4-d-old
ABe37fs/fs (ABfs/fs) neurons transfected with GFP and stained with MAP2,
treated with DMSO or taxol (Scale bar, 20 μm). The number of axons longer
than 10 μm is quantified (mean ± SEM; ***P < 0.001; 1-way ANOVA followed
by Dunnett’s multiple-comparisons test; n = 15, 21, 10, 10 from top to bot-
tom). (E) Schematic of branch formation in WT (up) versus ABe37fs/fs (ABfs/fs)
or L1CAM-Y1229H (down) in axon shaft, where microtubules are indicated














































































































































Fig. 7. Giant ankB colocalizes with L1CAM in periodic plasma membrane
domains and coordinates cortical microtubules. (A) Schematic and trans-
mission electron microscopy images of axon cross-sections at the corpus
callosum. Regular spaced black dots are microtubules (Scale bars, 100 nm).
(B) Histogram of distance of individual microtubules to the closest axon
membrane (n = 219, 184, 208 in WT, ABfs/fs, L1-Y1229H mice accordingly
with 2 mice per genotype, P < 0.0001 in both WT vs. ABfs/fs and WT vs. L1-
Y1229H; unpaired t test). (C). STED images of axons in cultured neurons that
were either phalloidin-labeled for actin (green) or double-labeled for giant
ankB (green) or L1CAM (red) (Scale bars, 5 μm). (D) The staining intensity of
actin (Upper Left) or giant ankB (Upper Right; Bottom) along the membrane
is displayed. (E) Histogram of F-actin or giant ankB periodicities of indicated
genotypes. For actin periodicity, P > 0.05; 1-way ANOVA. For giant ankB
periodicity, P = 0.01 in WT vs. ABfs/fs, P = 0.0003 in WT vs. L1-Y1229H; 1-way
ANOVA. (F) Schematic of giant ankB/L1CAM membrane complexes co-
ordinating cortical microtubules in an axon.
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regulation that do not occur in culture, such as axonal pruning,
axon bundling, or myelination.
We therefore used a brain-wide diffusion tensor imaging
(DTI) method to visualize axon tracts in whole brains of PND 28
WT and ABe37fs/fs mice. DTI is an MRI-based neuroimaging
technique used to determine the location and orientation of axon
tracts in 3D in an unbiased fashion over the whole brain (35, 36).
This unbiased approach was advantageous as our behavioral
results did not implicate a particular brain region. Using per-
fused brains, we scanned brains at 9.4T using 31 diffusion sen-
sitization directions for 7 h per animal, and reconstructed images
at 55-μm isotropic resolution across the entire brain. We first
determined whether ABe37fs/fs mice exhibited significant struc-
tural differences in brain morphology using the same MRI dataset
as for DTI, since some mouse models for autism exhibit macro-
cephaly (2). However, WT and ABe37fs/fs mice exhibited no
statistically significant differences in regional brain volumes after a
multiple-comparison correction, using a false-discovery rate of less
than 5% (Dataset S2). We next visualized tractography for brains
of WT and ABe37fs/fs mice and found no consistent differences in
major axon tracts (corpus callosum, anterior commissure, fimbria)
that were evident by visual inspection (Fig. 8A). Together, global
estimates of brain volumes and tractography reveal no major
structural differences between brains of WT and ABe37fs/fs mice.
Next, we examined whole brain pair-wise connectivity of white
matter tracks using fractional anisotropy in an atlas of 332 brain
regions from the DTI images (Materials and Methods). Strikingly,
this analysis revealed small but significant increases in connectivity
in 68% of pair-wise brain connections in ABe37fs/fs mice (Fig.
8B). The connections visualized by DTI are most likely not indi-
vidual axons, which are too small to image by this method, but
rather axon tracts or bundles.
High-functioning ASD patients exhibit increased variability in
functional brain connectivity, as well as stochastic increases in
interhemispheric asymmetry (37). We therefore evaluated in-
terhemispheric track asymmetry for either the entire brain or for
the cerebral cortex by performing voxel-based comparisons
within hemispheres of individual mice. This analysis revealed a
small difference in asymmetry for the whole brain, which was not
statistically significant (Fig. 8C). However, ABe37fs/fs cortexes
exhibited a significant increase in interhemispheric asymmetry of
long tracks (P = 0.01) (Fig. 8C).
In summary, DTI reveals that ABe37fs/fs mice exhibit overall
normal brain morphology and tractography of principal axon
tracts. These structural findings are in accord with their normal
learning and memory. However, quantitative analyses revealed
small increases in interhemispheric asymmetry in the cortex, as
well as overall increased connectivity that were not obvious
from visual inspection. The increased connectivity of ABe37fs/fs
mouse brains is consistent with increased axon branching ob-
served in cultured heterozygous and homozygous ABe37fs neu-
rons and ABe37f/f; Nestin-Cre neurons (Fig. 5 B and C), and
provides a rationale for penetrant behavioral differences ob-
served in ABe37fs and ABe22* mice that are heterozygous for
the giant ankB mutation/knockout (Fig. 2 E and F).
Discussion
We identify giant ankB as a functional neurospecific target for
nonsyndromic ASD mutation in ANK2, and reproduce penetrant
behavioral differences combined with normal learning and
memory in 3 mouse models with mutated/deficient giant ankB.
We find that human de novo R2608fs ASD mutation of giant
ankB, as well as a nearby P2580fs mutation, both result in ex-
pression of −290-kDa truncated ankB polypeptides. Cultured
neurons of mice bearing the P2580fs mutation exhibit increased
frequency of axonal branching that is rescued by expression of
WT giant ankB. We also find increased axon branching in giant
ankB knockout neurons, which is restored by WT giant ankB, but
not by giant ankB bearing human de novo ASD P1843S or
E3429V missense mutations (SI Appendix, Fig. S10). Mice bearing
the giant ankB P2580fs mutation exhibit stochastic increases in
structural connectivity in their cerebral cortices, as well as a tran-
sient increase in excitatory synapses during postnatal development.
We elucidate a cellular mechanism dependent on giant ankB and
its interaction with L1CAM and cortical microtubules that nor-
mally limits axon branching. Thus, gain of axon branching due to
giant ankB-deficiency/mutation is a candidate cellular mechanism
to explain aberrant structural connectivity with penetrant behav-
ioral consequences in mice as well as humans bearing high-function
ASD-related ANK2 mutations.
Interestingly, a similar mechanism utilizing giant ankyrins to
control microtubule position in axons has independently evolved
in fruit flies (38). However, giant exons of Drosophila and verte-
brate ankyrins likely rose independently since they share minimal











































































Fig. 8. ABe37fs mice have a gain of stochastic connectivity by DTI. (A) Brains of WT (AB+/+) and ABe37fs/fs (ABfs/fs) male PND 28 mice imaged based on
fractional anisotropy in black and white in coronal sections (Left) and in pseudocolor in 3D (Right). Positions of the corpus callosum (arrowheads), fimbria
(green asterisks), and anterior commissure (black box) are indicated. (B) Histogram of pair-wise connectivity fromWT and ABe37fs/fs brains. (C) Quantification
of interhemispheric voxel asymmetry analysis from tracks greater than 7 mm in length originating in the whole brain or whole cortex. n = 5 mice per ge-
notype; mean ± SEM; Kolmogorov–Smirnov test, 2-way, unpaired t test for B; 2-way, unpaired t test for C; *P < 0.05; ns, not significant.








sequence homology and are located at different sites within their
transcripts (16, 38). Drosophila giant exons are located at the 3′
ends of transcripts, while vertebrate giant exons are located in-
ternally between the death domain and spectrin-binding super-
module (15). In both cases, additional sequence is encoded by
giant exons and is enriched in segments predicted to be unstruc-
tured, resulting in highly extended polypeptides. The similarities of
axonal microtubule association, and extended structures of in-
dependently evolved giant ankyrins in Drosophila and vertebrates,
thus represent a striking example of convergent evolution.
Cortical microtubules are displaced toward the axoplasm
and away from axonal plasma membranes in ABe37fs/fs and
L1CAM Y1229H axons (Fig. 7B), indicating plasma membrane-
associated giant ankB interacts, either directly or indirectly, with
microtubules in vivo. Interestingly, 220-kDa ankB, which shares
all of its domains with giant ankB, associates with microtubules
in biochemical assays (39). Giant ankB also could interact with
microtubules through sequence encoded by its neurospecific
exon. It will be important in future work to identify the precise
nature of giant ankB interaction in vivo.
The increase in connectivity visualized by DTI is modest with
no significant volumetric changes, as would be expected to occur
from a major gain of axon branching (Fig. 8 and Dataset S2).
Similarly, a significant increase in branching in vivo was not
observed from viral injections into the cortex within the first
300 μm of pyramidal neuron axons (SI Appendix, Fig. S9). Based
on cultured neuronal experiments (Fig. 5B), in this length of
axon we would expect to see 5 to 10 branches, but instead
branches were rarely observed. This indicates that additional
mechanisms occur in vivo to regulate axon branching, which we
speculate could include restriction by myelination, axon re-
traction, and axon degeneration. In addition, the fasciculation of
axons is likely impaired in the giant ankB mutant brain due to
the irregular patterning of L1CAM in the axon as the periodic
L1CAM domains were recently reported to be aligned between
axons in contact with one another (33).
Abnormal synaptic function and gene regulation have received
the most attention as potential targets for ASD mutations (1, 2,
20). However, several considerations suggest that ectopic axonal
connectivity, as identified in our study, could also occur as a
consequence of mutation of ASD genes in addition to ANK2. For
example, increased axon branching has been reported in mice
deficient in PTEN, which is a high-confidence syndromic ASD-
susceptibility gene (40). Moreover, other high-confidence ASD-
associated genes including DYRK1A (a microtubule kinase) (41),
and KATNA1 (a microtubule-severing protein) (42), also affect
axonal microtubules and potentially could affect the frequency of
axon branching through a similar mechanism as giant ankB.
ASDs are currently viewed as highly variable due to genetic
and environmental diversity (43). However, giant ankB mutant
mice raised under identical conditions and back-crossed over
6 generations exhibit increased interhemispheric asymmetry in
cortical connectivity that parallels stochastic increases in inter-
hemispheric asymmetry in functional MRI reported for high-
functioning ASD in humans (37) (Fig. 8). Given that the right
and left hemispheres of the brain differ in the same mouse, it is
likely that individual mice will also differ in their connectivity.
Extending this reasoning to humans suggests that giant ankB
mutations may have highly variable consequences with respect to
effects on behavior and intellectual ability. It will be important in
future work to track both connectivity and behavior in individual
humans and mice bearing ANK2 mutation rather than averaging
data, as we have done in the present study.
Whole-exome data suggest giant ankB mutations may be un-
der some level of positive selection in human populations. For
example, a frameshift mutation in ANK2 exon 37 (Q2018Pfs*7,
c.6053_6057del5) similar in location to the frameshift mutation
in ABe37fs/fs mice is present in 0.28% of 6,231 individuals in the
whole-exome database of individuals of African American and
European American ethnicity (39). This frameshift is predicted
to cause a premature stop codon downstream of the 5-nucleotide
deletion and likely generates a truncated polypeptide similar to
R2608fs. Indeed, ASD has been associated with positive selec-
tion due to the involvement of neurogenesis and cognitive ability
genes (44).
In summary, giant ankB mutant mice provide neurospecific
mouse models for human nonsyndromic ASD mutation in exon
37 of ANK2. These mice exhibit overall normal brain morphol-
ogy and cognitive ability accompanied by ectopic axon projec-
tions that may have diverse consequences for behavior due to the
stochastic alterations to connectivity. Indeed, other neurodiversity
related conditions, such as synesthesia and conduct disorder, are
associated with increased structural connectivity (45, 46). More
generally, stochastic increases in connectivity due to branching of
axons may provide novel substrates for neurodiversity with bene-
fits in addition to limitations.
Materials and Methods
Detailed materials and methods can be found in SI Appendix, Materials
and Methods.
We generated knockin ABe37fs mice tomimic the de novo human variant at
amino acid 2608 of human ANK2. A gRNA (ATAGTCAGCATCGGGGTCCG AGG)
was designed to create a CRISPR-induced indel at S2580 to optimize gRNA
specificity. Abe37floxed mice were generated using BAC recombineering,
exon 37 was flanked by LoxP sites and a neomycin-resistance cassette that
was flanked by FRT sites was inserted between the end of exon 37 and the
downstream LoxP site. Exon 37 was removed from neuronal and glial pre-
cursors by crossing Abe37floxed mice with Nestin-Cre recombinase mice
[B6.Cg-Tg(Nes-cre)1Kln/J; JAX 003771].
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